3 YEARS IN, PROGRAM BUILDS ON CAPABILITY AND CONNECTIVITY FOR EARLY CAREER RESEARCHERS IN ENT MEDICAL DEVICES Beyond Science gives in theatre opportunities, networking with stakeholders and support from mentors
With
Professor Payal Mukherjee, Adult and Paediatric ENT Surgeon
Otologist, Cochlear Implant and Skull Base Surgeon &
Clinical Professor, Macquarie University &
TGA Advisory Committee for Medical Devices &
Clinical Associate Professor, University of Sydney &
Surgical Innovation Lead, RPA Institute of Academic Surgery &
Head of Department ENT, Sydney Adventist Hospital &
Co-Founder & Co-Director, Beyond Science
Distinguished Professor Gordon Wallace AO,
Director, Intelligent Polymer Research Institute,
University of Wollongong &
Co-Founder & Co-Director, Beyond Science
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Sydney & Wollongong | August 2025
Surgeon-scientists and surgeon-innovators have an important role in the entire medical technology translational cycle; not only from discovery to commercialisation, but in ensuring that health technologies are implemented in value-based manner.
This includes defining safety and regulatory standards, balancing patient outcomes against health care costs, and working with policy makers to ensure that funding is both sustainable and promotes equitable access to technology.
Despite a rich history of biomedical innovation in Australia, there are limited training opportunities for surgeons to develop these skills. Within NSW, there are no formal surgeon-scientist training pathways in Otolaryngology, Head and Neck Surgery.
In 2022, Distinguished Professor Gordon Wallace AO and Professor Mukherjee jointly established Beyond Science as a clinician led, academically supported and clinician run Australian-first medical technology translation program.
The program is aimed at early career researchers and clinician-scientists working in medical device research specifically in otolaryngology (ear, nose, and throat), head and neck surgery.
Its core mission is to build capability and foster connections between researchers and key stakeholders such as industry, government, universities, and health systems.
This is through helping researchers understand health system priorities and translation pathways from research to real-world impact. Uniquely, this includes opportunity to enter surgical environments for observation and tissue collection.
Australian Health Journal spoke to its founders about how it supports academic mentorship and creates networking opportunities to help early career stage medical device researchers connect with clinicians, policymakers, industry leaders, and funding bodies.
Beyond Science is funded by Passe & Williams Foundation & the Sydney Local Health District
Source: Adapted from Beyond Science, RACS and University of Wollongong websites
-
Bionic eye trial shows improvements in functional vision for retinitis pigmentosa
Results of the first clinical trial of Australia’s ‘second generation’ bionic eye have demonstrated ‘substantial improvement’ in four participants’ functional vision, daily activities and quality of life over a period of more than two and a half years.
Led by the Centre for Eye Research Australia, Bionics Institute, University of Melbourne and Royal Victorian Eye and Ear Hospital, the trial findings add to interim results which showed that the second-generation bionic eye developed by Australian company Bionic Vision Technologies provided rapid improvements for four patients with blindness caused the genetic eye condition retinitis pigmentosa.
-
Success in WA pilot to observe babies showing delays in social interaction & communication development
Inklings – led by The Kids Research Institute Australia – is a program for babies aged 6-18 months whose communications skills are developing differently to expected milestones. In early 2025 it has completed the first year of a pilot program.
At the time of filming (Nov 2024), Inklings has received more then 300 enquiries across WA and started to deliver services to 160 children, with almost 60 who have completed the program.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
